News
Global Cannabis News & Analysis | Business of Cannabis
News · page 3
- Hemp Industry
Could Animal Feed Be Hemp’s Way Out of the Oversupply Trap?
The US post-2018 Farm Bill hemp boom helped create a problem the industry is still wrestling with: too much flower and too few buyers.
- Adult-Use
Switzerland’s SCRIPT Trial Finds Regulated Cannabis Sales Change How People Consume, Not How Much
Government-led scientific studies from across Europe’s most progressive cannabis markets are solidifying an evidence base suggesting that greater access does not cause greater harm to public health.
- UK & Europe
The Netherlands’ Landmark Adult-Use Cannabis Experiment Publishes First Results
Initial findings from the Netherlands’ landmark ‘controlled cannabis supply chain experiment’ were submitted to the House of Representatives on September 9, the first published findings since the T0 baseline report, published in March 2024 (covering data collected in 2022).
- Medical Cannabis
Overdue ACMD Report Gets New Deadline as Industry Weighs In
By Ben Stevens, with additional reporting by Nicole Farah, Managing Director of Americana Communications.
- CBD Market
Chair of UK’s FSA Says Future of CBD Regulation Will ‘Lie With EU Authorisations’
The long-term future of Britain’s CBD sector ‘really will lie with EU authorisations’, the chair of the Food Standards Agency (FSA) has told its board, a candid admission that the domestic regime the industry has chased for six years may ultimately be superseded by Brussels.
- Cultivation
What APAC Producers Get Wrong About EU-GMP
Written by Dr Nickel Dittrich, Managing Director, GMPion When Asia-Pacific producers talk about Europe, the conversation usually starts in the grow room.
- Cultivation
Are US Cannabis Contracts Enforceable? A $32m Court Ruling Just Said No
A Michigan breach-of-contract dispute between cultivator Hello Farms and Curaleaf Holdings has cracked open a fault line that runs beneath every cannabis contract in the US, opening the door to a ‘mutually assured destruction’ defence that cannot be closed.
- Cultivation
France’s PGP Farmer Selects 5 Cannabis Strains for Future French Production as Market Nears Rollout
PGP Farmer, the French biotech building the country’s first EU-GMP medical cannabis production site, has narrowed a 30-variety Dutch phenotyping trial to five elite cultivars, laying the agronomic groundwork for its 9-hectare Dordogne facility as France closes on the reforms needed for full medical cannabis rollout.
- M&A Activity
Does Your IP Moat Your Business?
This article was written by Sean McLean, CEO & Co-Founder, Peregrine Precision Systems, and originally published here.
- Press releases
Prohibition Partners Announces New Growth Marketing Platform PPX, Welcoming Heidi Whitman as its MD
Prohibition Partners pairs a decade of cannabis market infrastructure with the international network of PPX’s new Managing Director.
- Medical Cannabis
UK Medical Cannabis Under Review: Where is the ACMD Report?
Pressure is piling on the UK’s Advisory Council on the Misuse of Drugs (ACMD) to publish its highly anticipated review of the country’s medical cannabis framework.
- Cultivation
Are We Underestimating the Pharmaceutical Potential of the Cannabis Plant?
James Duckenfield, CEO of Glass Pharms®, explains why we may be underestimating the pharmaceutical potential of cannabis, and how research, formulation and more controlled delivery could help realise it.
